Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)95

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)32

Views

Views
December 20252
January 20263
February 20262
March 20267
April 20260
May 20267
June 202611
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States20
Mexico3
Ecuador2
Brazil1
Colombia1
Algeria1
Lithuania1
Turkey1
Venezuela1
 

Top cities views

Views
San Jose8
Ashburn3
Bogotá1
Chlef1
Chula Vista1
Dallas1
Grosse Pointe1
Guayaquil1
Istanbul1
Juneau1